Literature DB >> 26475548

Vitiligo is not a cosmetic disease.

Khaled Ezzedine1, Vaneeta Sheth2, Michelle Rodrigues3, Viktoria Eleftheriadou4, John E Harris5, Iltefat H Hamzavi6, Amit G Pandya7.   

Abstract

Entities:  

Keywords:  autoimmune disease; burden; cosmetic; insurance payers; patient-reported outcomes; quality of life; reimbursement; vitiligo

Mesh：

Year:  2015        PMID： 26475548     DOI： 10.1016/j.jaad.2015.07.039

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  24 in total

Review 1.  The Role of Memory CD8+ T Cells in Vitiligo.

Authors:  Rebecca L Riding; John E Harris
Journal:  J Immunol       Date:  2019-07-01       Impact factor: 5.422

2.  Vitiligo: Patient stories, self-esteem, and the psychological burden of disease.

Authors:  P E Grimes; M M Miller
Journal:  Int J Womens Dermatol       Date:  2018-01-08

Review 3.  Understanding mechanisms of autoimmunity through translational research in vitiligo.

Authors:  James P Strassner; John E Harris
Journal:  Curr Opin Immunol       Date:  2016-10-17       Impact factor: 7.486

4.  Mouse Model for Human Vitiligo.

Authors:  Rebecca L Riding; Jillian M Richmond; John E Harris
Journal:  Curr Protoc Immunol       Date:  2018-09-25

5.  Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT.

Authors:  Jonathan M Batchelor; Kim S Thomas; Perways Akram; Jaskiran Azad; Anthony Bewley; Joanne R Chalmers; Seau Tak Cheung; Lelia Duley; Viktoria Eleftheriadou; Robert Ellis; Adam Ferguson; Jonathan Mr Goulding; Rachel H Haines; Hamdi Hamad; John R Ingram; Bisola Laguda; Paul Leighton; Nick Levell; Areti Makrygeorgou; Garry D Meakin; Adam Millington; Malobi Ogboli; Amirtha Rajasekaran; Jane C Ravenscroft; Andrew Rogers; Tracey H Sach; Miriam Santer; Julia Stainforth; Wei Tan; Shyamal Wahie; Jennifer White; Maxine E Whitton; Hywel C Williams; Andrew Wright; Alan A Montgomery
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

Review 6.  The Role of the NKG2D in Vitiligo.

Authors:  Lourdes Plaza-Rojas; José A Guevara-Patiño
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

7.  Novel Furocoumarin Derivatives Stimulate Melanogenesis in B16 Melanoma Cells by Up-Regulation of MITF and TYR Family via Akt/GSK3β/β-Catenin Signaling Pathways.

Authors:  Chao Niu; Li Yin; Haji Akber Aisa
Journal:  Int J Mol Sci       Date:  2018-03-06       Impact factor: 5.923

8.  Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy.

Authors:  Rebecca L Riding; Jillian M Richmond; Keitaro Fukuda; John E Harris
Journal:  Pigment Cell Melanoma Res       Date:  2020-10-26       Impact factor: 4.159

9.  Views and experiences of seeking information and help for vitiligo: a qualitative study of written accounts.

Authors:  Emma Teasdale; Ingrid Muller; Amirah Abdullah Sani; Kim S Thomas; Beth Stuart; Miriam Santer
Journal:  BMJ Open       Date:  2018-01-11       Impact factor: 2.692

10.  Serum Zinc Level in Vitiligo: A Case-control Study.

Authors:  Mina Mirnezami; Hoda Rahimi
Journal:  Indian J Dermatol       Date:  2018 May-Jun       Impact factor: 1.494
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.